Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Dubsky

Showing results (81-90 of 100) with videos related to

Pageof 10
Sort By:
Virchows Archiv : an International Journal of Pathology|May 9, 2020
Factors influencing agreement of breast cancer luminal molecular subtype by Ki67 labeling index between core needle biopsy and surgical resection specimensKristina A Tendl-Schulz, Fabian Rössler, Philipp Wimmer, et al.
The Lancet. Oncology|August 23, 2008
Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudyMichael Gnant, Brigitte Mlineritsch, Gero Luschin-Ebengreuth, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|February 15, 2020
"I was seen by a radiologist, but unfortunately I can't remember the name and I still have questions. What should I do?" Radiologists should give thoughts to improve service professionalism and patient esteemAndreas Gutzeit, Arne Fischmann, Rosemarie Forstner, et al.
The New England Journal of Medicine|February 14, 2009
Endocrine therapy plus zoledronic acid in premenopausal breast cancerMichael Gnant, Brigitte Mlineritsch, Walter Schippinger, et al.
BMJ Open|April 20, 2024
Protocol for the development of a core outcome set and reporting guidelines for locoregional treatment in neoadjuvant systemic breast cancer treatment trials: the PRECEDENT projectShelley Potter, Kerry Avery, Rosina Ahmed, et al.
Breast (Edinburgh, Scotland)|November 6, 2025
ESR1, PGR, ERBB2, and MKi67 mRNA expression in diagnostic core biopsies from breast cancer patients of the ABCSG Trial 34Stephanie Kacerovsky-Strobl, Christine Deutschmann, Dominik Hlauschek, et al.
Plos One|November 8, 2023
Understanding the needs of women undergoing breast ultrasound: Are male radiologists still needed?Elisabeth Sartoretti, Selina Largiadèr, Thomas Sartoretti, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 26, 2024
Exploring locoregional treatment reporting in neoadjuvant systemic breast cancer treatment studies: A systematic reviewMichael Jiang, Kerry Avery, Rosina Ahmed, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2014
The PAM50 risk-of-recurrence score predicts risk for late distant recurrence after endocrine therapy in postmenopausal women with endocrine-responsive early breast cancerMartin Filipits, Torsten O Nielsen, Margaretha Rudas, et al.
Breast Cancer Research and Treatment|June 5, 2017
First international consensus conference on standardization of oncoplastic breast conserving surgeryWalter P Weber, Savas D Soysal, Mahmoud El-Tamer, et al.
Pageof 10

Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
Virchows Archiv : an International Journal of Pathology|May 9, 2020
Factors influencing agreement of breast cancer luminal molecular subtype by Ki67 labeling index between core needle biopsy and surgical resection specimensKristina A Tendl-Schulz, Fabian Rössler, Philipp Wimmer, et al.
The Lancet. Oncology|August 23, 2008
Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudyMichael Gnant, Brigitte Mlineritsch, Gero Luschin-Ebengreuth, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|February 15, 2020
"I was seen by a radiologist, but unfortunately I can't remember the name and I still have questions. What should I do?" Radiologists should give thoughts to improve service professionalism and patient esteemAndreas Gutzeit, Arne Fischmann, Rosemarie Forstner, et al.
The New England Journal of Medicine|February 14, 2009
Endocrine therapy plus zoledronic acid in premenopausal breast cancerMichael Gnant, Brigitte Mlineritsch, Walter Schippinger, et al.
BMJ Open|April 20, 2024
Protocol for the development of a core outcome set and reporting guidelines for locoregional treatment in neoadjuvant systemic breast cancer treatment trials: the PRECEDENT projectShelley Potter, Kerry Avery, Rosina Ahmed, et al.
Breast (Edinburgh, Scotland)|November 6, 2025
ESR1, PGR, ERBB2, and MKi67 mRNA expression in diagnostic core biopsies from breast cancer patients of the ABCSG Trial 34Stephanie Kacerovsky-Strobl, Christine Deutschmann, Dominik Hlauschek, et al.
Plos One|November 8, 2023
Understanding the needs of women undergoing breast ultrasound: Are male radiologists still needed?Elisabeth Sartoretti, Selina Largiadèr, Thomas Sartoretti, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 26, 2024
Exploring locoregional treatment reporting in neoadjuvant systemic breast cancer treatment studies: A systematic reviewMichael Jiang, Kerry Avery, Rosina Ahmed, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2014
The PAM50 risk-of-recurrence score predicts risk for late distant recurrence after endocrine therapy in postmenopausal women with endocrine-responsive early breast cancerMartin Filipits, Torsten O Nielsen, Margaretha Rudas, et al.
Breast Cancer Research and Treatment|June 5, 2017
First international consensus conference on standardization of oncoplastic breast conserving surgeryWalter P Weber, Savas D Soysal, Mahmoud El-Tamer, et al.
Pageof 10